Characteristics of children with asthma who are enrolled in a Head Start program

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 3, 2004, Pages 499-504

  Vargas, Perla A ^a,b   Simpson, Pippa M ^a   Gary Wheeler, J ^a   Goel, Rajiv ^a   Feild, Charles R ^a   Tilford, John M ^a   Jones, Stacie M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

African American; allergy; Arkansas; asthma; atopy; ED; Emergency department; environmental tobacco exposure; Environmental tobacco smoke; ETS; Head Start; HS; low income; minority; NHLBI; OTC; Over the counter; preschool aged

Indexed keywords

ADRENALIN; ALLERGEN; ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; COTININE; DIMETAPP; DIPHENHYDRAMINE; EXPECTORANT AGENT; GUAIFENESIN; IBUPROFEN; LONG ACTING DRUG; PARACETAMOL; PEDIACARE; PSEUDOEPHEDRINE; SHORT ACTING DRUG; STEROID; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ARTICLE; CAREGIVER; DEMOGRAPHY; EMERGENCY WARD; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH CARE; HEALTH SURVEY; HUMAN; HUMIDIFIER; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION; SKIN TEST; SMOKING; VAPORIZER;

AFRICAN AMERICANS; ARKANSAS; ASTHMA; CHILD, PRESCHOOL; EARLY INTERVENTION (EDUCATION); ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TOBACCO SMOKE POLLUTION;

EID: 4444327059     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.05.025     Document Type: Article

References (30)

1. Centers for Disease Control. Surveillance for asthma - United States, 1960-1995. Morb Mortal Wkly Rep. 47:(SS-1):1998;1-28
2. United States Vital Statistics. 1996;National Center for Health Statistics, Hyattsville (MD)
3. Halfon N., Newacheck P.W. Childhood asthma and poverty: differential impacts and utilization of health services. Pediatrics. 91:1993;56-61
4. Malveaux F.J., Houlihan D., Diamond E.L. Characteristics of asthma mortality and morbidity in African-Americans. J Asthma. 30:1993;431-437. [See comment.]
5. Weitzman M., Gortmaker S., Sobol A. Racial, social, and environmental risks for childhood asthma. Am J Dis Child. 144:1990;1189-1194
6. Lang D.M., Sherman M.S., Polansky M. Guidelines and realities of asthma management. The Philadelphia story. Arch Intern Med. 157:1997;1193-1200
7. Goodman D.C., Stukel T.A., Chang C.H. Trends in pediatric asthma hospitalization rates: regional and socioeconomic differences. Pediatrics. 101:1998;208-213
8. Wood D.L., Hayward R.A., Corey C.R., Freeman H.E., Shapiro M.F. Access to medical care for children and adolescents in the United States. Pediatrics. 86:1990;666-673
9. Kattan M., Mitchell H., Eggleston P., Gergen P., Crain E., Redline S., et al. Characteristics of inner-city children with asthma: the National Cooperative Inner-City Asthma Study. Pediatr Pulmonol. 24:1997;253-262
10. Wood R.A. Pediatric asthma. [review] JAMA. 288:2002;745-747
11. Fosarelli P., DeAngelis C., Kaszuba A. Compliance with follow-up appointments generated in a pediatric emergency room. Am J Prev Med. 1:1985;23-29
12. Zigler E., Valentine J. Project Head Start. A legacy of the war on poverty. 2nd ed. :1997;The National Head Start Association, Alexandria (VA)
13. Jones C.A., Morphew T., Clement L.T., Kimia T., Dyer M., Li M., et al. A school-based case identification process for identifying inner city children with asthma: the Breathmobile program. Chest. 125:2004;924-934
14. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. [National Institutes of Health Publication No. 97-4051]. 1997;National Institutes of Health, Bethesda (MD)
15. Greenberg R.A., Haley N.J., Etzel R.A., Loda F.A. Measuring the exposure of infants to tobacco smoke. Nicotine and cotinine in urine and saliva. New Engl J Med. 310:1984;1075-1078
16. Perez-Stable E.J., Herrera B., Jacob P. III, Benowitz N.L. Nicotine metabolism and intake in black and white smokers. JAMA. 280:1998;152-156. [See comment.]
17. Cornelius M.D., Goldschmidt L., Dempsey D.A. Environmental tobacco smoke exposure in low-income 6-year-olds: parent report and urine cotinine measures. Nicotine Tob Res. 5:2003;333-339
18. Winkelstein M.L., Tarzian A., Wood R.A. Parental smoking behavior and passive smoke exposure in children with asthma. Ann Allergy Asthma Immunol. 78:1997;419-423. [See comment.]
19. Chilmonczyk B.A., Salmun L.M., Megathlin K.N., Neveux L.M., Palomaki G.E., Knight G.J., et al. Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. New Engl J Med. 328:1993;1665-1669. [See comment.]
20. SAS 9.1. Cary (NC): Statistical Package SAS Institute Inc; 2004.
21. Ladebauche P., Nicolosi R., Reece S., Saucedo K., Volicer B., Richards T. Asthma in Head Start children: prevalence, risk factors, and health care utilization. Pediatr Nurs. 27:2001;396-399
22. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen, Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. New Engl J Med. 332:1995;133-138. [See comments.]
23. Haahtela T. The long-term influence of therapeutic interventions in asthma with emphasis on inhaled steroids and early disease. [Review.] Clin Exp Allergy. 28:(suppl 5):1998;133-140
24. Haahtela T., Jarvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. New Engl J Med. 331:1994;700-705. [See comment.]
25. Laitinen L.A., Laitinen A., Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 90:1992;32-42
26. Haahtela T., Jarvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. New Engl J Med. 325:1991;388-392. [See comment.]
27. Blais L., Suissa S., Boivin J.F., Ernst P. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax. 53:1998;1025-1029. [See comment.]
28. Blais L., Ernst P., Boivin J.F., Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med. 158:1998;126-132
29. Konig P. Irreversible airway obstruction in childhood asthma? A clinician's viewpoint. Pediatr Pulmonol. 33:(4):2002;307-310
30. McGill K.A., Sorkness C.A., Ferguson-Page C., Gern J.E., Havighurst T.C., Knipfer, et al. Asthma in non-inner city Head Start children. Pediatrics. 102:(1 Pt 1):1998;77-83